The glial scar is not just a barrier—it is a failed compromise between protection and repair

After spinal cord injury, the glial scar forms to seal the wound and limit inflammation. But this same structure locks in the damage by blocking axon regeneration. The key players are chondroitin sulfate proteoglycans (CSPGs), molecules that physically repel growing axons. New research shows CSPGs are not the whole story—and targeting them alone is not enough.